Catalyst Wire Dossier Catalyst Wire Dossier

PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein

pegylated recombinant coagulation factor VIII-Fc fusion protein · Jiangsu Gensciences Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein, covering 2023-05-15 to 2023-05-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection [Phase 2]

See pricing